Introduction
Hemoglobinopathy, which consists of thalassemia and hemoglobin variant (1) , is the most frequent genetic disorder found in the world. Its prevalence in Indonesia is about 10%. A screening program has been proposed to prevent an increasing number or new case of thalassemia. (2) Early screening of hemoglobinopathy using complete blood count (CBC) generally shows a normal or slightly RESULTS: A total 202 subjects who met the criteria were involved in this study. Fifty percent showed pure hemoglobinopathy and 4% showed a combination of thalassemia and hemoglobinopathy. The hemoglobin concentration and RBC were significantly higher, and the mean corpuscular volume (MCV) and RDW were significantly lower in hemoglobinopathy compared to iron deficiency. The difference was not significant if the hemoglobinopathy was combined with iron deficiency. By this study's cut-off, the G&K and RDWI showed the highest accuracy, sensitivity, and specificity.
CONCLUSION:
The new cut-off of erythrocyte index and its calculation to screen hemoglobinopathy in Indonesia showed a higher sensitivity and specificity, especially for G&K and RDWI with cut-off 73 and 228, respectively. The presence of iron deficiency in hemoglobinopathy could decrease the sensitivity.
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decrease of hemoglobin level with a low mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH), but a high red blood cell distribution width (RDW). These characteristics are not only found in hemoglobinopathy, but it also could be found in iron deficiency and chronic disease. The treatment of these three conditions is not similar, whereas iron supplementation is indicated for iron deficiency, but it is not indicated for hemoglobinopathy and chronic disease.(3) Therefore, further examinations, such as iron level, total iron binding capacity (TIBC), ferritin, evaluation of hemoglobin A 2 (HbA 2 ), hemoglobin F (HbF), and the presence of an abnormal hemoglobin fraction should be performed.(4) However, the cost of these further examination is high and not all health care in Indonesia provide the facility to do all of these tests. Therefore, analysis of CBC result should be optimized.
Some formulas derived from erythrocytes indices have been reported to distinguish between thalassemia and other causes.(4-11) An appropriate cut-off of reported formulas should be redetermined to increase the sensitivity and specificity of thalassemia screening in one population because the spectrums of mutation of thalassemia are different among population which might result in different values of erythrocytes indices. (12) (13) (14) (15) This study aimed to evaluate red blood cell count (RBC) and some formulas using erythrocytes indices, such as Mentzer index, RDW, RDW index (RDWI), Shine and Lal index (S&L), and Green and King index (G&K) for hemoglobinopathy screening in Indonesia.
This was a retrospective cross-sectional study that was performed in Prodia Clinical Laboratory (Jakarta, Indonesia) in 2015-2016 and the ethical clearance of this study had been approved by Medical Faculty of Trisakti University, with Ethical Number 73/KER/FK/III/2015.
Two hundred and two patients who underwent thalassemia screening and showed low MCV and MCH were recruited in this study. Subjects who had white blood cell count greater than 20% of its reference range, or had a history of blood transfusion within previous 3 months were excluded from this study.
The diagnosis of hemoglobinopathy was determined and classified by Clinical Pathologist based on an evaluation of CBC result, erythrocytes morphology, the presence of Hemoglobin H (HbH) inclusion bodies, and the result of hemoglobin fraction using high-performance liquid chromatography (HPLC) method. Beta thalassemia trait, if the erythrocyte showed microcytic hypochromic, low MCV, low MCH, and HbA2 fraction was between 3.5-5.0% or slightly greater in some case of mutation. Heterozygote Hemoglobin E (HbE) (trait), if the erythrocyte showed microcytic hypochromic, low MCV, low MCH, and HbA 2 fraction was about 30%. Beta-thalassemia/HbE double heterozygote, if the erythrocyte was microcytic hypochromic, low MCV, low MCH, HbA 2 was between 40-60%, and HbF was between 5-87%.(16) Alpha trait
Methods
Results thalassemia, if the erythrocyte was slightly microcytic hypochromic, low MCV, low MCH, HbA 2 fraction was normal or slightly decreased, HbF was generally normal, Hb Bart's as 0.8-11% could be present in the first 3 months of life, and HbH inclusion body could be found but very rare.(1,16) Diagnosis of HbH disease was based on the presence of microcytic hypochromic erythrocyte, low MCV, low MCH, HbA 2 was between 1-2%, HbF was between 1-3.5%, and a large amount of HbH inclusion bodies were found (35-90% of RBC). The presence of alpha thalassemia trait could not be excluded if the erythrocyte was microcytic hypochromic, low MCV, low MCH, the HbA 2 fraction was equal to or less than 3.5%, but the HbH inclusion body was not found, and ferritin level was not decreased. (16) The presence of iron deficiency was determined if the ferritin level was less than the reference value. If hemoglobinopathy was present with iron deficiency, it was classified as a combination of hemoglobinopathy and iron deficiency.
Subject who classified as "combination of hemoglobinopathy and iron deficiency" or "alpha thalassemia trait could not be excluded" were not included for cut-off analysis. The CBC data from the instrument, such as hemoglobin concentration, RBC, MCV, MCH and RDW as part of routine hematology measurement were recorded. These data were used for some calculation of formulas to predict hemoglobinopathy, such as, (1) Subjects involved in this study aged between 0.6-76 years old (mean 30 years old). The characteristics of the subjects were shown in Table 1 .
The median of erythrocytes indices showed significant differences among groups (Figure 1 ). Hemoglobin concentration and RBC were significantly higher, but MCV and RDW were significantly lower in hemoglobinopathy compared to iron deficiency. But if the hemoglobinopathy was combined with iron deficiency, there were not any significant differences in these parameters between the subject with hemoglobinopathy only and subject with a combination of hemoglobinopathy and iron deficiency.
The cut-off of RBC, Mentzer index, RDW, RDWI, S&L and G&K were determined using receiver operating curve (ROC) ( Table 2) . To obtain the cut-off, we calculated 164 data of 63 subjects with iron deficiency and 101 subjects with hemoglobinopathy. The highest accuracy to predict hemoglobinopathy was obtained with G&K and RDWI (Table 3 ). There were 75% subjects with combination of hemoglobinopathy and iron deficiency that could be accurately identified by RBC or G&K using our cut-off (Table 4 ). In subjects that we classified as could not be excluded for alpha thalassemia trait, there was a possibility of alpha thalassemia trait of 3.3-83.3% based on erythrocyte index and its calculation (Table 5) . Table 3 . Percentage accuration to predict hemoglobinopathy obtained from literature and current study. Table 2 . The cut-off of erythrocytes indices and its sensitivity-specificity from literature and current study.
Discussion
Hemoglobinopathy (thalassemia or variant hemoglobin) is a genetic disorder of globin synthesis which is required for hemoglobin production. The clinical manifestation of hemoglobinopathy is varied, ranges from asymptomatic to symptoms that need repeated transfusion. Screening of hemoglobinopathy using CBC examination is very useful. Erythrocyte index from CBC data and its calculation with some formula could predict the possibility of beta thalassemia. If the result indicates a possibility of hemoglobinopathy, further analysis using other methods, such as electrophoresis, HPLC, or DNA analysis should be performed to confirm the result. Unfortunately, the cost of the test is quite high and the test does not always available in routine practice. (3, 15, 17) This study involved 202 patients from many regions in Indonesia who underwent thalassemia screening and fulfilled the study's criteria. Most of the subjects were female (74.3%). The most common etiology of microcytic hypochromic erythrocytes in this study was hemoglobinopathy (50%); the others were iron deficiency (31.2%), combination of hemoglobinopathy and iron deficiency (4%) and 14.9% cases could not be excluded for alpha thalassemia trait (Table 1) . Another study that involved 901 patients who had microcytic hypochromic erythrocyte and underwent thalassemia screening showed nearly similar result with ours, 49.2% subjects had beta thalassemia, and the rest were due to iron deficiency or other causes. (18) Thalassemia patients usually show microcytic hypochromic erythrocytes with high RBC. (17) This study also showed a high median value of RBC (5.6 millions/ µL). All erythrocyte indices showed significant differences between iron deficiency and hemoglobinopathy subjects, except MCH (Figure 1) . The RBC and hemoglobin concentration were significantly higher, but the MCV and RDW were significantly lower in hemoglobinopathy compared to iron deficiency (hemoglobinopathy vs. Table 4 . The percentage of correct prediction of hemoglobinopathy in subjects with combination of hemoglobinopathy and iron deficiency. to in hemoglobinopathy the disorder happened only in hemoglobin synthesis, not in erythrocytes synthesis, but in iron deficiency, the disorder happened both in erythrocyte and hemoglobin synthesis. Subjects with a combination of hemoglobinopathy and iron deficiency showed higher RBC and hemoglobin concentration compared to subjects with pure iron deficiency, but the MCV and RDW did not show a significant difference between both groups (combination of hemoglobinopathy and iron deficiency vs. iron deficiency: RBC = 5.03 vs. 4.41, Hb = 10.7 vs. 9.3). But, the RBC and hemoglobin concentration within subjects with pure hemoglobinopathy (no combination with iron deficiency) were higher compared to those in subjects with combination of hemoglobinopathy and iron deficiency (Figure 1) . It was suggested that the presence of iron deficiency in hemoglobinopathy patients influenced the RBC and hemoglobin concentration that yield a lower result compared to pure hemoglobinopathy.
Erythrocyte indices and their calculation could help to screen the diagnosis of thalassemia, especially beta thalassemia.(10) Thalassemia mutation spectrum in each population are not similar, so that the erythrocyte indices will be different among populations. Therefore, a cut-off in one population should be determined to increase the sensitivity and specificity of thalassemia. (12) (13) (14) (15) In this study, we analyzed 164 data to determine the cut-off using ROC curve. There were different results in sensitivity and specificity between literature cut-off and this study cut-off (Table 2) . Bordbar studied about this in Iran population who asked for premarital screening. The study showed that the new cut-off did not yield 100% sensitivity and the highest sensitivity as 87.6% was shown by S&L. (19) This study showed higher sensitivity was obtained if we used our cut-off than literature cut-off, except for S&L. The highest sensitivity and specificity were obtained by G&K (sensitivity 90.0%, specificity 92.0%) and RDWI (sensitivity 88.0%, specificity 92.0%) ( Table  2) . Miri-Monghaddam determined their own cut-off in Iran population, and that study showed that G&K index showed the highest sensitivity (84%) and specificity (84%) to differentiate iron deficiency anemia and beta trait thalassemia. (13) In this study, the highest accuracy was obtained by G&K index and RDWI, 91.1% and 90.9% respectively (Table 3) . A study by Miri-Monghaddam showed that the highest accuracy of hemoglobinopathy was obtained by G&K index (AUC 90.9%) (13) , whereas Niazi's study showed that the highest accuracy was obtained by RDWI (AUC 88.4 %). (20) In this study, there were 10 of 101 subjects (9.9%) diagnosed as hemoglobinopathy but could not be detected using G&K or RDWI. These 10 subjects consisted of 5 subjects with beta thalassemia trait, 3 subjects with HbH disease, and 2 subjects with beta-thalassemia/HbE double heterozygote. There were 2 subjects with beta-thalassemia/ HbE double heterozygote in this study, but both subjects could not be detected have a hemoglobinopathy with all formula that we studied, except S&L. There were 3 of 6 subjects of all HbH disease subjects that could be detected by RDWI or G&K, but a greater number of these subjects could be detected by RBC (83.3%). There were 2 other subjects that could not be detected have a hemoglobinopathy using RDWI, 1 HbE trait subject and 1 beta thalassemia trait subject.
There were 75% subjects with combination of hemoglobinopathy and iron deficiency that could be correctly predicted having a hemoglobinopathy using RBC count and G&K index (Table 4 ). Urrechaga found there were 19.5% of subjects with combination of hemoglobinopathy and iron deficiency that could not be detected have a hemoglobinopathy and were classified as iron deficiency anemia. It would be more difficult to detect hemoglobinopathy by erythrocyte indices calculation if iron deficiency was also present.(21) It might be due to lower RBC count and hemoglobin concentration which were found if iron deficiency was present with hemoglobinopathy as explained above would influence the result of the calculation.
There were 30 subjects that could not be excluded for the possibility of alfa trait thalassemia. This was classified based on undetectable HbH inclusion body and normal/high ferritin level in subjects with microcytic hypochromic anemia and normal/slightly low HbA 2 . HbH inclusion body is important marker to help the diagnosis of alpha thalassemia. In some cases, HbH might not be detected. In one alpha gene deletion (-α/αα) or two gene deletion trans type (-α/-α) HbH is more difficult to be found and the MCV or the RBC usually show a closer value to the reference range compared to two alpha gene deletion cis type (--/αα).(22) Using our cut-off, there were still 3.33-83.3% possibilities of having alpha trait thalassemia in group of subjects with alpha thalassemia could not be excluded (Table 5) . To confirm this, DNA analysis is required.
This study concluded RDWI and G&K with our own cut-off, 228 and 73, respectively, showed the highest accuracy, sensitiviy and specificity for hemoglobinopathy screening in Indonesia. The presence of iron deficiency in hemoglobinopathy could decrease the sensitivity of
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